(Lecture)MEXT Innovation System Development Project, Osaka Regional Development Fund Support Project Seminar “Personalized Medicine: Current and Future Issues Part 2” “Government Policy on Health ICT and Precision Medicine and Its Impact on Japan”
date : 2/16/2016
Toshio Miyata, HGPI Executive Director facilitated a panel discussion and delivered the keynote speech titled, “Government Policy on Health ICT and Precision Medicine and Its Impact on Japan,” at the MEXT Innovation System Development Project, Osaka Regional Development Fund Support Project Seminar “Personalized Medicine: Current and Future Issues Part2.”
Top Research & Recommendations Posts
- [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines (September 7, 2020)
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [New Research Project] Initiative for the Advancement of Dementia Research and Social System Innovation through Global Public Private Partnerships (PPP)
